Not applicableStudy completedNCT02850289
What this trial is testing
APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin
Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 385